Applied Genetic Technologies (AGTC) Misses Q3 EPS by 4c, Sales Miss

Applied Genetic Technologies (NASDAQ: AGTC) reported Q3 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $10.45 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13